Preadmission beta-blocker use and 30-day mortality among patients in intensive care: a cohort study


INTRODUCTION Beta-blockers have cardioprotective, metabolic and immunomodulating effects that may be beneficial to patients in intensive care. We examined the association between preadmission beta-blocker use and 30-day mortality following intensive care. METHODS We identified 8,087 patients over age 45 admitted to one of three multidisciplinary intensive… (More)
DOI: 10.1186/cc10085


2 Figures and Tables

Slides referencing similar topics